Regenerex Patella Components
510(k) K083782
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK083782 | Date3 Apr 2009 | StatusActive |
Recalls
-
- Terminated Z-2146-2020
Potential presence of elevated endotoxin levels that exceed the specification limit
-
- Terminated Z-2068-2017
pegs shearing post-operatively
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MBH
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3565
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Regenerex Patella Components are orthopedic implants designed as part of a modular knee replacement system. These components are intended for use in total knee arthroplasty, providing a porous titanium patellar button to facilitate bone ingrowth and integration. The design supports cementless fixation, enhancing long-term stability and reducing the need for cement application during surgery. They are categorized under orthopedic implants and fall under the product code MBH.
These components are supplied sterile and intended for single-use in surgical settings. They are manufactured from porous titanium, ensuring biocompatibility and osseointegration with the patient’s bone. The device is regulated under FDA 510(k) clearance (K083782) and is classified as a Class II medical device. Storage and handling must adhere to sterile surgical protocols to maintain integrity before use.
Other devices from Biomet Manufacturing Corp
Questions
AI-generated answers, 1 Oct 2026
What is the Regenerex Patella Components used for?
The Regenerex Patella Components are designed as part of a modular knee replacement system for total knee arthroplasty. They provide a porous titanium patellar button that encourages bone ingrowth, enabling cementless fixation. This design reduces the need for surgical cement and supports long-term stability of the knee implant.
Are the Regenerex Patella Components sterile and single-use?
Yes, the Regenerex Patella Components are supplied sterile and intended for single-use in surgical settings. Sterility ensures safety for patients, and single-use reduces the risk of cross-contamination and maintains device integrity.
What material is used in the Regenerex Patella Components?
The components are manufactured from porous titanium, a material chosen for its biocompatibility and ability to integrate with bone through osseointegration. This promotes stable fixation without the need for cement.
How should the Regenerex Patella Components be stored?
Storage must follow strict sterile surgical protocols to preserve the device’s integrity before use. This includes maintaining proper packaging, avoiding contamination, and adhering to manufacturer guidelines for shelf life and environmental conditions.
What regulatory clearance does the Regenerex Patella Components hold?
The Regenerex Patella Components have received FDA 510(k) clearance under the reference number K083782. This clearance confirms that the device is substantially equivalent to a legally marketed predicate device and is classified as a Class II medical device.